BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9557616)

  • 1. The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction.
    Croockewit AJ; Raymakers RA; Smeets ME; vd Bosch G; Pennings AH; de Witte TJ
    Leukemia; 1998 Apr; 12(4):571-7. PubMed ID: 9557616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
    Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
    Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
    Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
    Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123.
    Leemhuis T; Yoder MC; Grigsby S; Agüero B; Eder P; Srour EF
    Exp Hematol; 1996 Aug; 24(10):1215-24. PubMed ID: 8765497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle.
    Gothot A; Pyatt R; McMahel J; Rice S; Srour EF
    Blood; 1997 Dec; 90(11):4384-93. PubMed ID: 9373249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.
    Verfaillie CM; Almeida-Porada G; Wissink S; Zanjani ED
    Exp Hematol; 2000 Sep; 28(9):1071-9. PubMed ID: 11008020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
    Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
    J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
    Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
    Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased stroma adhesion capacity of CD34+ progenitor cells from mobilized peripheral blood is not lineage- or stage-specific and is associated with low beta 1 and beta 2 integrin expression.
    Carion A; Domenech J; Hérault O; Benboubker L; Clément N; Bernard MC; Desbois I; Colombat P; Binet C
    J Hematother Stem Cell Res; 2002 Jun; 11(3):491-500. PubMed ID: 12183834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody BB9 raised against bone marrow stromal cells identifies a cell-surface glycoprotein expressed by primitive human hemopoietic progenitors.
    Ramshaw HS; Haylock D; Swart B; Gronthos S; Horsfall MJ; Niutta S; Simmons PJ
    Exp Hematol; 2001 Aug; 29(8):981-92. PubMed ID: 11495704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells.
    Pyatt RE; Jenski LL; Allen R; Cornetta K; Abonour R; Traycoff CM; Srour EF
    J Hematother; 1999 Apr; 8(2):189-98. PubMed ID: 10349913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
    Theunissen K; Verfaillie CM
    Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.